Schneider launches Wallstent in U.S. for iliac use.
This article was originally published in The Gray Sheet
Executive Summary
SCHNEIDER LAUNCHES WALLSTENT IN U.S. FOR ILIAC USE following FDA's May 28 approval of the self- expanding metallic device. The approval covers use of Wallstent in patients whose iliac arteries "have narrowed following angioplasty to treat atherosclerosis," Schneider says. Wallstent already is on the U.S. market for biliary, tracheobronchial, and esophageal indications.